Journal of Alzheimers Disease

Article	Citations
Short-Chain Fatty Acids and Lipopolysaccharide as Mediators Between Gut Dysbiosis and Amyloid Pathology in Alzheimer’s Disease	204
Artificial Intelligence, Speech, and Language Processing Approaches to Monitoring Alzheimer’s Disease: A Systematic Review	113
Gut Microbiome Features of Chinese Patients Newly Diagnosed with Alzheimer’s Disease or Mild Cognitive Impairment	101
Association of COVID-19 with New-Onset Alzheimer’s Disease	100
Hypoxia, Oxidative Stress, and Inflammation: Three Faces of Neurodegenerative Diseases	91
Current and Future Prevalence Estimates of Mild Cognitive Impairment, Dementia, and Its Subtypes in a Population-Based Sample of People 70 Years and Older in Norway: The HUNT Study	85
Mild Behavioral Impairment and Subjective Cognitive Decline Predict Cognitive and Functional Decline	83
Polyphenols as Potential Metal Chelation Compounds Against Alzheimer’s Disease	83
Promoting Successful Cognitive Aging: A Ten-Year Update	82
Alzheimer’s Disease: Key Insights from Two Decades of Clinical Trial Failures	81
The Impact of Dementia on the Clinical Outcome of COVID-19: A Systematic Review and Meta-Analysis	81
Therapeutic Potential of TNF-α Inhibition for Alzheimer’s Disease Prevention	78
Post-Stroke Cognitive Impairment: Epidemiology, Risk Factors, and Management	75
Cognitive Effects of Aerobic Exercise in Alzheimer’s Disease: A Pilot Randomized Controlled Trial	69
Gut Microbiota Changes and Their Correlation with Cognitive and Neuropsychiatric Symptoms in Alzheimer’s Disease	69
The Locus Coeruleus in Aging and Alzheimer’s Disease: A Postmortem and Brain Imaging Review	68
Vitamin D Supplementation Improves Cognitive Function Through Reducing Oxidative Stress Regulated by Telomere Length in Older Adults with Mild Cognitive Impairment: A 12-Month Randomized Controlled Tr	65
NLRP3 Inflammasome: A Starring Role in Amyloid-β- and Tau-Driven Pathological Events in Alzheimer’s Disease	62
Benfotiamine and Cognitive Decline in Alzheimer’s Disease: Results of a Randomized Placebo-Controlled Phase IIa Clinical Trial	58
Impact of Social Isolation on People with Dementia and Their Family Caregivers	56
Dementia and COVID-19, a Bidirectional Liaison: Risk Factors, Biomarkers, and Optimal Health Care	56
Investigating Casual Associations Among Gut Microbiota, Metabolites, and Neurodegenerative Diseases: A Mendelian Randomization Study	54
tRNA-Derived Fragments in Alzheimer’s Disease: Implications for New Disease Biomarkers and Neuropathological Mechanisms	54
One-Year Aerobic Exercise Reduced Carotid Arterial Stiffness and Increased Cerebral Blood Flow in Amnestic Mild Cognitive Impairment	53
The Role of Microglia in Sporadic Alzheimer’s Disease	50

The Potential Role of Ferroptosis in Alzheimer’s Disease	50
Potential Involvement of Varicella Zoster Virus in Alzheimer’s Disease via Reactivation of Quiescent Herpes Simplex Virus Type 1	50
Effect of Probiotic Bifidobacterium breve in Improving Cognitive Function and Preventing Brain Atrophy in Older Patients with Suspected Mild Cognitive Impairment: Results of a 24-Week Randomized, Doub	49
Association of Stress with Risk of Dementia and Mild Cognitive Impairment: A Systematic Review and Meta-Analysis	48
Bile Acids as Key Modulators of the Brain-Gut-Microbiota Axis in Alzheimer’s Disease	48
Behavioral and Psychological Symptoms of Dementia in Different Dementia Disorders: A Large-Scale Study of 10,000 Individuals	48
New Frontiers in the Prevention, Diagnosis, and Treatment of Alzheimer’s Disease	47
Is the Frontal Lobe the Primary Target of SARS-CoV-2?	46
A Randomized Clinical Trial of Greek High Phenolic Early Harvest Extra Virgin Olive Oil in Mild Cognitive Impairment: The MICOIL Pilot Study	46
Alzheimer’s Disease Neuropathological Comorbidities are Common in the Younger-Old	46
Sexual Dimorphism in the 3xTg-AD Mouse Model and Its Impact on Pre-Clinical Research	46
Plasma Glial Fibrillary Acidic Protein Levels Differ Along the Spectra of Amyloid Burden and Clinical Disease Stage1	46
High Cholesterol Diet Exacerbates Blood-Brain Barrier Disruption in LDLr–/– Mice: Impact on Cognitive Function	45
Safety and Efficacy of Monoclonal Antibodies for Alzheimer’s Disease: A Systematic Review and Meta-Analysis of Published and Unpublished Clinical Trials	44
Dietary Pattern, Diet Quality, and Dementia: A Systematic Review and Meta-Analysis of Prospective Cohort Studies	44
Neuropsychiatric Symptoms in Patients with Dementia Associated with Increased Psychological Distress in Caregivers During the COVID-19 Pandemic	43
A Novel Inhibitor Targeting NLRP3 Inflammasome Reduces Neuropathology and Improves Cognitive Function in Alzheimer’s Disease Transgenic Mice	43
Risk of Alzheimer’s Disease Following Influenza Vaccination: A Claims-Based Cohort Study Using Propensity Score Matching	43
Particulate Matter Exposure Exacerbates Amyloid-β Plaque Deposition and Gliosis in APP/PS1 Mice	43
Death Rate Due to COVID-19 in Alzheimer’s Disease and Frontotemporal Dementia	40
A Primer on the Evolution of Aducanumab: The First Antibody Approved for Treatment of Alzheimer’s Disease	40
Race/Ethnic Disparities in Mild Cognitive Impairment and Dementia: The Northern Manhattan Study	40
The Latin America and the Caribbean Consortium on Dementia (LAC-CD): From Networking to Research to Implementation Science	40
Alpha Power and Functional Connectivity in Cognitive Decline: A Systematic Review and Meta-Analysis	40
Sex Differences in Behavior and Molecular Pathology in the 5XFAD Model	39
Associations Between Caffeine Consumption, Cognitive Decline, and Dementia: A Systematic Review	39
MIND Diet, Common Brain Pathologies, and Cognition in Community-Dwelling Older Adults	39
Photobiomodulation Enhances Memory Processing in Older Adults with Mild Cognitive Impairment: A Functional Near-Infrared Spectroscopy Study	38
Structural Change of Gut Microbiota in Patients with Post-Stroke Comorbid Cognitive Impairment and Depression and Its Correlation with Clinical Features	38
Life Course Air Pollution Exposure and Cognitive Decline: Modelled Historical Air Pollution Data and the Lothian Birth Cohort 1936	38
Altered Gut Microbiota in Adults with Subjective Cognitive Decline: The SILCODE Study	38
Modifiable Barriers for Recruitment and Retention of Older Adults Participants from Underrepresented Minorities in Alzheimer’s Disease Research	37
A Review of Oxidative Stress Products and Related Genes in Early Alzheimer’s Disease	37
Grey Matter Loss at Different Stages of Cognitive Decline: A Role for the Thalamus in Developing Alzheimer’s Disease	37
COVID-19: Association Between Increase of Behavioral and Psychological Symptoms of Dementia During Lockdown and Caregivers’ Poor Mental Health	36
Soluble Amyloid-β Consumption in Alzheimer’s Disease	36
Precision Medicine Approach to Alzheimer’s Disease: Successful Pilot Project	36
Copper Imbalance in Alzheimer’s Disease and Its Link with the Amyloid Hypothesis: Towards a Combined Clinical, Chemical, and Genetic Etiology	36
The Impact of a Global Pandemic on People Living with Dementia and Their Care Partners: Analysis of 417 Lived Experience Reports	35
Model-Based Projection of Dementia Prevalence in China and Worldwide: 2020–2050	35
In vitro Characterization of the Regional Binding Distribution of Amyloid PET Tracer Florbetaben and the Glia Tracers Deprenyl and PK11195 in Autopsy Alzheimer’s Brain Tissue	35
Synaptic Mitochondria: An Early Target of Amyloid-β and Tau in Alzheimer’s Disease	35
Selective Secretase Targeting for Alzheimer’s Disease Therapy	34
The Role of D-Amino Acids in Alzheimer’s Disease	34
A Comparison of Behavioral and Psychological Symptoms of Dementia (BPSD) and BPSD Sub-Syndromes in Early-Onset and Late-Onset Alzheimer’s Disease	34
Functional Integrity of Synapses in the Central Nervous System of Cognitively Intact Individuals with High Alzheimer’s Disease Neuropathology Is Associated with Absence of Synaptic Tau Oligomers	34
Mesenchymal Stem Cell-Conditioned Medium Improves Mitochondrial Dysfunction and Suppresses Apoptosis in Okadaic Acid-Treated SH-SY5Y Cells by Extracellular Vesicle Mitochondrial Transfer	34
Loneliness, Not Social Support, Is Associated with Cognitive Decline and Dementia Across Two Longitudinal Population-Based Cohorts	34
Serum Phosphatidylethanolamine and Lysophosphatidylethanolamine Levels Differentiate Alzheimer’s Disease from Controls and Predict Progression from Mild Cognitive Impairment	34
Mind Diet Adherence and Cognitive Performance in the Framingham Heart Study	33

Modifiable, Non-Modifiable, and Clinical Factors Associated with Progression of Alzheimer’s Disease	33
Social Stigma of People with Dementia	32
Impact of 40 Hz Transcranial Alternating Current Stimulation on Cerebral Tau Burden in Patients with Alzheimer’s Disease: A Case Series1	32
Burnout of Healthcare Workers in Acute Care Geriatric Facilities During the COVID-19 Crisis: An Online-Based Study	32
Egocentric and Allocentric Spatial Memory in Mild Cognitive Impairment with Real-World and Virtual Navigation Tasks: A Systematic Review	32
Social Robot Interventions for People with Dementia: A Systematic Review on Effects and Quality of Reporting	32
Photobiomodulation Therapy for Dementia: A Systematic Review of Pre-Clinical and Clinical Studies	32
Visual Impairment, Eye Diseases, and Dementia Risk: A Systematic Review and Meta-Analysis	32
Association Between Inflammatory Bowel Disease and Dementia: A Retrospective Cohort Study	32
Olfactory Dysfunction Is Already Present with Subjective Cognitive Decline and Deepens with Disease Severity in the Alzheimer’s Disease Spectrum	31
Longitudinal Cerebral Blood Flow Changes in Normal Aging and the Alzheimer’s Disease Continuum Identified by Arterial Spin Labeling MRI	31
A Narrative Review of Alzheimer’s Disease Stigma	31
Porphyromonas gingivalis Outer Membrane Vesicles as the Major Driver of and Explanation for Neuropathogenesis, the Cholinergic Hypothesis, Iron Dyshomeostasis, and Salivary Lactoferrin in Alzheimer’s	31
Blood-Based ATN Biomarkers of Alzheimer’s Disease: A Meta-Analysis	31
The Potential Contribution of Chronic Pain and Common Chronic Pain Conditions to Subsequent Cognitive Decline, New Onset Cognitive Impairment, and Incident Dementia: A Systematic Review and Conceptual	30
Recursive Support Vector Machine Biomarker Selection for Alzheimer’s Disease	30
High Soluble Amyloid-β42 Predicts Normal Cognition in Amyloid-Positive Individuals with Alzheimer’s Disease-Causing Mutations	30
Cognitive Impairment Is a Common Comorbidity in Deceased COVID-19 Patients: A Hospital-Based Retrospective Cohort Study	30
Cannabidiol Ameliorates Cognitive Function via Regulation of IL-33 and TREM2 Upregulation in a Murine Model of Alzheimer’s Disease	30
Comparative Analysis of Alzheimer’s Disease Cerebrospinal Fluid Biomarkers Measurement by Multiplex SOMAscan Platform and Immunoassay-Based Approach1	30
Probiotic Bifidobacterium breve Prevents Memory Impairment Through the Reduction of Both Amyloid-β Production and Microglia Activation in APP Knock-In Mouse1	29
Anti-Aβ Antibody Aducanumab Regulates the Proteome of Senile Plaques and Closely Surrounding Tissue in a Transgenic Mouse Model of Alzheimer’s Disease	29
Severe Obstructive Sleep Apnea Is Associated with Higher Brain Amyloid Burden: A Preliminary PET Imaging Study	29
Alzheimer’s Disease, Neural Plasticity, and Functional Recovery	29
Phenylalanine Metabolism Is Dysregulated in Human Hippocampus with Alzheimer’s Disease Related Pathological Changes	29
Role of Hypoxia Inducible Factor-1α in Alzheimer’s Disease	29
Low Doses of Ionizing Radiation as a Treatment for Alzheimer’s Disease: A Pilot Study	29
Needs of Dementia Family Caregivers in Spain During the COVID-19 Pandemic	29
Quantitative Study of the Changes in Cerebral Blood Flow and Iron Deposition During Progression of Alzheimer’s Disease	29
Key Intervention Categories to Provide Person-Centered Dementia Care: A Systematic Review of Person-Centered Interventions	28
Ethnic Differences in Dementia Risk: A Systematic Review and Meta-Analysis	28
Quantitative Assessment of Resting-State for Mild Cognitive Impairment Detection: A Functional Near-Infrared Spectroscopy and Deep Learning Approach	28
Design Considerations for Mobile Health Applications Targeting Older Adults	28
Cerebral Blood Flow Predicts Conversion of Mild Cognitive Impairment into Alzheimer’s Disease and Cognitive Decline: An Arterial Spin Labeling Follow-up Study	28
Gut Microbiota Alterations and Cognitive Impairment Are Sexually Dissociated in a Transgenic Mice Model of Alzheimer’s Disease	28
Influence of the Microbiota-Gut-Brain Axis on Cognition in Alzheimer’s Disease	27
A Systematic Review of the Association Between Psychological Stress and Dementia Risk in Humans	27
Classifying Non-Dementia and Alzheimer’s Disease/Vascular Dementia Patients Using Kinematic, Time-Based, and Visuospatial Parameters: The Digital Clock Drawing Test	27
Time to Diagnosis in Young Onset Alzheimer’s Disease: A Population-Based Study from Central Norway	27
Cognition at Each Stage of Lewy Body Disease with Co-occurring Alzheimer’s Disease Pathology1	27
Plasma Neurofilament Light Chain Predicts Cognitive Progression in Prodromal and Clinical Dementia with Lewy Bodies	27
The Alzheimer’s Disease Mitochondrial Cascade Hypothesis: A Current Overview	27
Multicenter Study on Sleep and Circadian Alterations as Objective Markers of Mild Cognitive Impairment and Alzheimer’s Disease Reveals Sex Differences	26
Olfactory Impairment Is Related to Tau Pathology and Neuroinflammation in Alzheimer’s Disease	26
Neuromodulation for Apathy in Alzheimer’s Disease: A Double-Blind, Randomized, Sham-Controlled Pilot Study	26
Alteration of Gut Microbiota in Alzheimer’s Disease and Their Relation to the Cognitive Impairment	26
Combining Multimodal Behavioral Data of Gait, Speech, and Drawing for Classification of Alzheimer’s Disease and Mild Cognitive Impairment	26
The Oral and Fecal Microbiota in a Canadian Cohort of Alzheimer’s Disease	26
A Comparison of Traditional and Serious Game-Based Digital Markers of Cognition in Older Adults with Mild Cognitive Impairment and Healthy Controls	25
Metabotropic Glutamate Receptors in Alzheimer’s Disease Synaptic Dysfunction: Therapeutic Opportunities and Hope for the Future	25
Brain Tissue-Derived Extracellular Vesicles in Alzheimer’s Disease Display Altered Key Protein Levels Including Cell Type-Specific Markers	25
Environmental Nanoparticles, SARS-CoV-2 Brain Involvement, and Potential Acceleration of Alzheimer’s and Parkinson’s Diseases in Young Urbanites Exposed to Air Pollution	25
Multidomain Intervention for Reversal of Cognitive Frailty, Towards a Personalized Approach (AGELESS Trial): Study Design	25
Living Alone with Mild-To-Moderate Dementia: Findings from the IDEAL Cohort	25
Low Liver Enzymes and Risk of Dementia: The Atherosclerosis Risk in Communities (ARIC) Study	25
Antemortem Visit-To-Visit Blood Pressure Variability Predicts Cerebrovascular Lesion Burden in Autopsy-Confirmed Alzheimer’s Disease	24
Upregulation of Cortical A2A Adenosine Receptors Is Reflected in Platelets of Patients with Alzheimer’s Disease	24
Relationships Between the Deposition of Amyloid-β and Tau Protein and Glymphatic System Activity in Alzheimer’s Disease: Diffusion Tensor Image Study	24
Screening for Early-Stage Alzheimer’s Disease Using Optimized Feature Sets and Machine Learning	24
The Role of the Microbiota-Gut-Brain Axis in the Health and Illness Condition: A Focus on Alzheimer’s Disease	24
Pilot Study on Dose-Dependent Effects of Transcranial Photobiomodulation on Brain Electrical Oscillations: A Potential Therapeutic Target in Alzheimer’s Disease	24
Gender/Sex Differences in the Association of Mild Behavioral Impairment with Cognitive Aging	24
RETRACTED: Effects of Folic Acid Combined with DHA Supplementation on Cognitive Function and Amyloid-β-Related Biomarkers in Older Adults with Mild Cognitive Impairment by a Randomized, Double Blind,	24
Association of Malnutrition with Functional and Cognitive Trajectories in People Living with Dementia: A Five-Year Follow-Up Study	24
Distinct Atrophy Pattern of Hippocampal Subfields in Patients with Progressive and Stable Mild Cognitive Impairment: A Longitudinal MRI Study	24
Does Mild Traumatic Brain Injury Increase the Risk for Dementia? A Systematic Review and Meta-Analysis	24
Prevalence and Risk of Mild Cognitive Impairment in Low and Middle-Income Countries: A Systematic Review	24
Structural Changes in Thalamic Nuclei Across Prodromal and Clinical Alzheimer’s Disease	24
Long-Term Blood Pressure Variability Across the Clinical and Biomarker Spectrum of Alzheimer’s Disease	24
Social Connectivity is Related to Mild Cognitive Impairment and Dementia	23
Distinct Profile Differences in Subjective Cognitive Decline in the General Public Are Associated with Metacognition, Negative Affective Symptoms, Neuroticism, Stress, and Poor Quality of Life	23
Depressive Symptoms Imputed Across the Life Course Are Associated with Cognitive Impairment and Cognitive Decline	23
Sense of Purpose in Life Is Associated with Lower Risk of Incident Dementia: A Meta-Analysis	23
Acceptance and Usability of Immersive Virtual Reality in Older Adults with Objective and Subjective Cognitive Decline	23
Retinal Amyloid Imaging for Screening Alzheimer’s Disease	23
Oral Health Status in Subjects with Amnestic Mild Cognitive Impairment and Alzheimer’s Disease: Data from the Zabút Aging Project	23
Exploring the Use of Intracranial and Extracranial (Remote) Photobiomodulation Devices in Parkinson’s Disease: A Comparison of Direct and Indirect Systemic Stimulations	23
Plasma Total-Tau and Neurofilament Light Chain as Diagnostic Biomarkers of Alzheimer’s Disease Dementia and Mild Cognitive Impairment in Adults with Down Syndrome	23
Different Inflammatory Signatures in Alzheimer’s Disease and Frontotemporal Dementia Cerebrospinal Fluid	23
Corneal Nerve and Brain Imaging in Mild Cognitive Impairment and Dementia	23

Paraoxonase 1, B Vitamins Supplementation, and Mild Cognitive Impairment	23
Obesity Measures in Relation to Cognition in the Northern Manhattan Study	23
A Review of Brain Atrophy Subtypes Definition and Analysis for Alzheimer’s Disease Heterogeneity Studies	23
Obesity-Associated Neurodegeneration Pattern Mimics Alzheimer’s Disease in an Observational Cohort Study	23
Voxelwise Meta-Analysis of Gray Matter Abnormalities in Mild Cognitive Impairment and Subjective Cognitive Decline Using Activation Likelihood Estimation	23
Supplementation With Carotenoids, Omega-3 Fatty Acids, and Vitamin E Has a Positive Effect on the Symptoms and Progression of Alzheimer’s Disease	22
Effects of Photobiomodulation on Changes in Cognitive Function and Regional Cerebral Blood Flow in Patients with Mild Cognitive Impairment: A Pilot Uncontrolled Trial	22
Polygenic Risk Scores in Alzheimer’s Disease Genetics: Methodology, Applications, Inclusion, and Diversity	22
Reliability of Telephone and Videoconference Methods of Cognitive Assessment in Older Adults with and without Dementia	22
Associations Between Neighborhood Park Access and Longitudinal Change in Cognition in Older Adults: The Multi-Ethnic Study of Atherosclerosis	22
The Efficacy and Safety of Alzheimer’s Disease Therapies: An Updated Umbrella Review	22
Cortical Thickness and Its Association with Clinical Cognitive and Neuroimaging Markers in Cerebral Amyloid Angiopathy	22
Prions and Neurodegenerative Diseases: A Focus on Alzheimer’s Disease	22
Potential Novel Genes for Late-Onset Alzheimer’s Disease in East-Asian Descent Identified by APOE-Stratified Genome-Wide Association Study	22
Relationship of Homocysteine Plasma Levels with Mild Cognitive Impairment, Alzheimer’s Disease, Vascular Dementia, Psychobehavioral, and Functional Complications	22
COVID-19 Crisis Effects on Caregiver Distress in Neurocognitive Disorder	22
Borrelia burgdorferi Co-Localizing with Amyloid Markers in Alzheimer’s Disease Brain Tissues	22
Non-Alcoholic Fatty Liver Disease, Liver Fibrosis, and Regional Amyloid-β and Tau Pathology in Middle-Aged Adults: The Framingham Study	22
Changes in Biothiol Levels Are Closely Associated with Alzheimer’s Disease	22
A GLP-1/GIP Dual Receptor Agonist DA4-JC Effectively Attenuates Cognitive Impairment and Pathology in the APP/PS1/Tau Model of Alzheimer’s Disease1	22
Photobiomodulation Therapy Attenuates Anxious-Depressive-Like Behavior in the TgF344 Rat Model	22
A Tale of Two Diseases: Exploring Mechanisms Linking Diabetes Mellitus with Alzheimer’s Disease	22
Effect of Lecanemab and Donanemab in Early Alzheimer’s Disease: Mechanistic Interpretation in the Amyloid Cascade Hypothesis 2.0 Perspective	22
Mortality in Dementia from 1996 to 2015: A National Registry-Based Cohort Study	22
Future Directions for Dementia Risk Reduction and Prevention Research: An International Research Network on Dementia Prevention Consensus	22
Obesity and White Matter Neuroinflammation Related Edema in Alzheimer’s Disease Dementia Biomarker Negative Cognitively Normal Individuals	22
Does Gender Influence the Relationship Between High Blood Pressure and Dementia? Highlighting Areas for Further Investigation	21
Targeted Metabolomic Analysis in Alzheimer’s Disease Plasma and Brain Tissue in Non-Hispanic Whites	21
COVID-19 Case Fatality and Alzheimer’s Disease	21
Cerebrospinal Fluid C18 Ceramide Associates with Markers of Alzheimer’s Disease and Inflammation at the Pre- and Early Stages of Dementia	21
The Retinal Vessel Density Can Reflect Cognitive Function in Patients with Alzheimer’s Disease: Evidence from Optical Coherence Tomography Angiography	21
Relationship of Neighborhood Greenness to Alzheimer’s Disease and Non-Alzheimer’s Dementia Among 249,405 U.S. Medicare Beneficiaries	21
Association Between Use of Sodium-Glucose Co-Transporter-2 (SGLT2) Inhibitors and Cognitive Function in a Longitudinal Study of Patients with Type 2 Diabetes	21
An Artificial Intelligence-Assisted Method for Dementia Detection Using Images from the Clock Drawing Test	21
Association Between Low-Density Lipoprotein Cholesterol Levels, Statin Use, and Dementia in Patients followed in German General Practices	21
Codon Usage Analysis of Pro-Apoptotic Bim Gene Isoforms	21
Reduction of Dendritic Inhibition in CA1 Pyramidal Neurons in Amyloidosis Models of Early Alzheimer’s Disease	21
Efficacy and Moderators of Virtual Reality for Cognitive Training in People with Dementia and Mild Cognitive Impairment: A Systematic Review and Meta-Analysis	21
Prolonged Treatment with Centella asiatica Improves Memory, Reduces Amyloid-β Pathology, and Activates NRF2-Regulated Antioxidant Response Pathway in 5xFAD Mice	21
Detection of Mild Cognitive Impairment in an At-Risk Group of Older Adults: Can a Novel Self-Administered Serious Game-Based Screening Test Improve Diagnostic Accuracy?	21
Economic Burden of Alzheimer’s Disease Dementia in Japan	21
Olfaction, Cognitive Impairment, and PET Biomarkers in Community-Dwelling Older Adults	21
Insulin Resistance as a Common Link Between Current Alzheimer’s Disease Hypotheses	21
Environmental Enrichment Effects on the Brain-Derived Neurotrophic Factor Expression in Healthy Condition, Alzheimer’s Disease, and Other Neurodegenerative Disorders	21
Examination of the Effect of Rare Variants in TREM2, ABI3, and PLCG2 in LOAD Through Multiple Phenotypes	21
Clinical and Imaging Determinants of Neurocognitive Disorders in Post-Acute COVID-19 Patients with Cognitive Complaints	21
Brainstem Volumetric Integrity in Preclinical and Prodromal Alzheimer’s Disease	21
Personalized Repetitive Transcranial Magnetic Stimulation for Primary Progressive Aphasia	21
The Novel Role of Mitochondrial Citrate Synthase and Citrate in the Pathophysiology of Alzheimer’s Disease	21
Playing Russian Roulette with Alzheimer’s Disease Patients: Do the Cognitive Benefits of Lecanemab Outweigh the Risk of Edema, Stroke and Encephalitis?	21
Partial Inhibition of Mitochondrial Complex I Reduces Tau Pathology and Improves Energy Homeostasis and Synaptic Function in 3xTg-AD Mice	20
Traumatic Brain Injury and Risk of Alzheimer’s Disease and Related Dementias in the Population	20
Why Inclusion Matters for Alzheimer’s Disease Biomarker Discovery in Plasma	20
Hemochromatosis Mutations, Brain Iron Imaging, and Dementia in the UK Biobank Cohort	20
White Matter Changes on Diffusion Tensor Imaging in the FINGER Randomized Controlled Trial	20
Interaction Between Diet and Microbiota in the Pathophysiology of Alzheimer’s Disease: Focus on Polyphenols and Dietary Fibers	20
The Neuroprotective and Neurodegeneration Effects of Heme Oxygenase-1 in Alzheimer’s Disease	20
Validity of the MemTrax Memory Test Compared to the Montreal Cognitive Assessment in the Detection of Mild Cognitive Impairment and Dementia due to Alzheimer’s Disease in a Chinese Cohort	20
The Influence of Socioeconomic Deprivation on Dementia Mortality, Age at Death, and Quality of Diagnosis: A Nationwide Death Records Study in England and Wales 2001–2017	20
Systemic Exposure to Lipopolysaccharide from Porphyromonas gingivalis Induces Bone Loss-Correlated Alzheimer’s Disease-Like Pathologies in Middle-Aged Mice	20
The Protective Mechanism of SIRT1 in the Regulation of Mitochondrial Biogenesis and Mitochondrial Autophagy in Alzheimer’s Disease	20
Association Between Dietary Fish and PUFA Intake in Midlife and Dementia in Later Life: The JPHC Saku Mental Health Study	20
Associations Between Obesity and Alzheimer’s Disease: Multiple Bioinformatic Analyses	20
Peripheral Markers of Vascular Endothelial Dysfunction Show Independent but Additive Relationships with Brain-Based Biomarkers in Association with Functional Impairment in Alzheimer’s Disease	20
Ameliorating Ribosylation-Induced Amyloid-β Pathology by Berberine via Inhibiting mTOR/p70S6K Signaling	20
Aluminum and Neurofibrillary Tangle Co-Localization in Familial Alzheimer’s Disease and Related Neurological Disorders	20
Associations Between Brain Volumes and Cognitive Tests with Hypertensive Burden in UK Biobank	20
An Investigation into the Effects of Outer Membrane Vesicles and Lipopolysaccharide of Porphyromonas gingivalis on Blood-Brain Barrier Integrity, Permeability, and Disruption of Scaffolding Proteins i	20
Aducanumab (Marketed as Aduhelm) Approval Is Likely Based on Misinterpretation of PET Imaging Data	20
Droplet Degeneration of Hippocampal and Cortical Neurons Signifies the Beginning of Neuritic Plaque Formation	20
A Brief Digital Cognitive Assessment for Detection of Cognitive Impairment in Cuban Older Adults	20
5-Hydroxymethylcytosine Signatures in Circulating Cell-Free DNA as Diagnostic Biomarkers for Late-Onset Alzheimer’s Disease	20
Making the Case for Accelerated Withdrawal of Aducanumab	20
Is Engagement in Intellectual and Social Leisure Activities Protective Against Dementia Risk? Evidence from the English Longitudinal Study of Ageing1	20
Serum Levels of α-Klotho Are Correlated with Cerebrospinal Fluid Levels and Predict Measures of Cognitive Function	20
Site-Specific Cerebrospinal Fluid Tau Hyperphosphorylation in Response to Alzheimer’s Disease Brain Pathology: Not All Tau Phospho-Sites are Hyperphosphorylated	20
Infectious Disease Burden and the Risk of Alzheimer’s Disease: A Population-Based Study	20
Loneliness and Cognitive Function in Older Adults Without Dementia: A Systematic Review and Meta-Analysis	20
Semantic Memory as an Early Cognitive Marker of Alzheimer’s Disease: Role of Category and Phonological Verbal Fluency Tasks	19
Neural Correlates of Mild Behavioral Impairment: A Functional Brain Connectivity Study Using Resting-State Functional Magnetic Resonance Imaging	19
Gut Inflammation Induced by Dextran Sulfate Sodium Exacerbates Amyloid-β Plaque Deposition in the AppNL–G–F Mouse Model of Alzheimer’s Disease	19
ANMerge: A Comprehensive and Accessible Alzheimer’s Disease Patient-Level Dataset	19
Ventral Tegmental Area Disconnection Contributes Two Years Early to Correctly Classify Patients Converted to Alzheimer’s Disease: Implications for Treatment	19
The Effects of Virtual Reality-Based Education on Empathy and Understanding of the Physical Environment for Dementia Care Workers in Australia: A Controlled Study	19
Language Network Connectivity Increases in Early Alzheimer’s Disease	19
Cognitive Function Associated with Gut Microbial Abundance in Sucrose and S-Adenosyl-L-Methionine (SAMe) Metabolic Pathways	19
Neuropathology of Anti-Amyloid-β Immunotherapy: A Case Report	19
Association of Occupational Factors and Dementia or Cognitive Impairment: A Systematic Review and Meta-Analysis	19
Plasma Biomarkers of Alzheimer’s Disease in African Americans	19
The FDA Approves Aducanumab for Alzheimer’s Disease, Raising Important Scientific Questions1	19
Cortical Thickness, Volume, and Surface Area in the Motoric Cognitive Risk Syndrome	19
Race-Related Association between APOE Genotype and Alzheimer’s Disease: A Systematic Review and Meta-Analysis	19
Associations of Neuropsychiatric Features with Cerebrospinal Fluid Biomarkers of Amyloidogenesis and Neurodegeneration in Dementia with Lewy Bodies Compared with Alzheimer’s Disease and Cognitively He	18
Neuronal Hyperexcitability in APPSWE/PS1dE9 Mouse Models of Alzheimer’s Disease	18
A Community-Based Study Identifying Metabolic Biomarkers of Mild Cognitive Impairment and Alzheimer’s Disease Using Artificial Intelligence and Machine Learning	18